News & Opinion

Covering the life sciences inside and out

Most Recent

Notch determines B cell fate

By | April 24, 2002

RBP-J signaling is involved in cell fate determination of marginal zone B cells in the spleen.

0 Comments

Support for use of animals in research

By | April 24, 2002

The UK government has set out in full for the first time its policy on the use of animals in medical research.

0 Comments

2002 Gairdner International Awards announced

By | April 23, 2002

The 2002 awards recognize the impact of genomics, proteomics and bioinformatics.

0 Comments

Anti-malarial mechanism unraveled

By | April 23, 2002

For more than 50 years antifolate drug therapy has been used successfully to treat malaria caused by Plasmodium falciparum. It had been assumed that differences between host and parasite in terms of the drug binding to dihydrofolate reductase-thymidylate synthase (DHFR-TS) were responsible for this success. But, in 19 April Science, Kai Zhang and Pradipsinh Rathod of University of Washington, Seattle, show that it may be differences in the regulation of DHFR between host and parasite that explai

0 Comments

Retroviral risk

By | April 23, 2002

Gene therapy with retroviral vectors can increase the risk of developing leukemia.

0 Comments

Wilson leaves UPenn's gene therapy institute

By | April 23, 2002

Director oversaw experiment that led to death of 18-year-old patient in 1999.

0 Comments

Control of bone remodelling

By | April 22, 2002

Constant remodelling of bones — up to 10% of the total mass every year — helps to maintain the optimal levels of calcium in the blood and also the structural function of the skeleton, but the identity of the molecules involved in controlling this process remains unclear. In April 18 Nature, Hiroshi Takayanagi and colleagues from University of Tokyo show that interferon-β (IFN-β) is pivotal in regulating bone homeostasis (Nature 2002, 416:744-749).Takayanagi et al. observed

0 Comments

FOXO transcription factor stimulates repair

By | April 22, 2002

The protein kinase Akt promotes cell survival by phosphorylating and inhibiting FOXO forkhead transcription factors. FOXO factors have been linked to stress responses and the regulation of longevity. In the April 19 Science, Hien Tran and colleagues at Boston's Children's Hospital define a role for the FOXO3a family member in the response to DNA damage (Science 2002, 296:530-534).Tran et al. created a Rat-1 fibroblast cell line expressing a tamoxifen-inducible FOXO3a protein. FOXO3a expression r

0 Comments

Nematode susceptibility genes

By | April 22, 2002

Parasitic nematode infections show a characteristic grouping among hosts, but the genes that predispose humans to these infections remain unknown. In April 16 online Proceedings of National Academy of Sciences, Sarah Williams-Blangero and colleagues from Southwest Foundation for Biomedical Research show that genes on chromosomes 1 and 13 are significant for the human infection with the roundworm Ascaris lumbricoides (Proc Natl Acad Sci USA 2002, 99:5533-5538).Williams-Blangero et al. performed a

0 Comments

Green revolution

By | April 19, 2002

The 'green revolution' refers to the development of improved crops, such as the high-yield semi-dwarf (sd) rice variant called IR8 that saved the world from a chronic food shortage in the 1960s. In the April 18 Nature, Sasaki et al. describe the molecular characterization of the IR8 variant (Nature 2002, 416:701-702).Mutation of the sd1 gene is the reason for IR8's short stature. Sasaki et al. report that sd1 encodes an oxidase enzyme involved in the biosynthesis of the plant hormone gibberellin

0 Comments

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham